Demant A/S (CPH:DEMANT)
200.00
-3.60 (-1.77%)
Apr 28, 2026, 4:59 PM CET
Demant Market Cap
Demant has a market cap or net worth of 42.18 billion as of April 28, 2026. Its market cap has decreased by -8.67% in one year.
Market Cap
42.18B
Enterprise Value
61.91B
Revenue
22.97B
Ranking
n/a
PE Ratio
17.86
Stock Price
200.00
Market Cap Chart
Since November 21, 1995, Demant's market cap has increased from 2.12B to 42.18B, an increase of 1,890.60%. That is a compound annual growth rate of 10.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 42.94B | -6.33% |
| Dec 30, 2025 | 45.84B | -20.30% |
| Dec 30, 2024 | 57.52B | -10.34% |
| Dec 29, 2023 | 64.15B | 51.17% |
| Dec 30, 2022 | 42.43B | -47.09% |
| Dec 30, 2021 | 80.20B | 39.08% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.17T |
| Genmab | 104.79B |
| Coloplast | 90.94B |
| ALK-Abelló | 50.78B |
| H. Lundbeck | 41.81B |
| Zealand Pharma | 21.40B |
| Ambu A/S | 17.20B |
| Bavarian Nordic | 14.28B |